CAS 1383982-64-6

Formula: C26H28N4O

InChI: InChI=1S/C26H28N4O/c1-4-5-18-12-21(16-28-15-18)19-6-7-20-14-25(10-8-22(31-3)9-11-25)26(23(20)13-19)29-17(2)24(27)30-26/h6-7,12-13,15-16,22H,8-11,14H2,1-3H3,(H2,27,30)/t22?,25?,26-/m0/s1

InChI key: WKDNQONLGXOZRG-BOPKNSRXSA-N

SMILES: CC#CC1=CC(=CN=C1)C2=CC3=C(CC4([C@]35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2

Lanabecestat

CAS: 1383982-64-6

Lanabecestat

Formula: C₂₆H₂₈N₄O

Purezza: ≥98%

Peso molecolare: 412.53

Ref: 54-BUP21807

(1α,1′R,4β)-4-Methoxy-5′′-methyl-6′-[5-(1-propyn-1-yl)-3-pyridinyl]dispiro[cyclohexane-1,2′-[2H]indene-1′(3′H),2′′-[2H]imidazol]-4′′-amine

CAS: 1383982-64-6

Formula: C₂₆H₂₈N₄O

Purezza: 99%

Colore e forma: Solid

Peso molecolare: 412.5267

Ref: IN-DA009D1I

Lanabecestat

CAS: 1383982-64-6

Lanabecestat (AZD3293) is a BACE1 inhibitor (Ki: 0.4 nM), Lanabecestat is used in the study of neurological diseases like Alzheimer's disease.

Formula: C₂₆H₂₈N₄O

Purezza: 98.55%

Colore e forma: Solid

Peso molecolare: 412.5267

Ref: TM-TQ0238

Lanabecestat

CAS: 1383982-64-6

Lanabecestat is an investigational drug, classified as a beta-secretase (BACE) inhibitor, which is derived from synthetic chemical processes. Its mode of action involves inhibiting the enzyme beta-secretase, which plays a crucial role in the amyloidogenic pathway by cleaving amyloid precursor protein (APP) into amyloid-beta peptides. The accumulation of these peptides is a hallmark of Alzheimer's disease pathology.

Formula: C₂₆H₂₈N₄O

Purezza: Min. 95%

Colore e forma: Powder

Peso molecolare: 412.53 g/mol

Ref: 3D-IFC98264